Tumor Profiling: Adding Proteomics to Genomics

    Cancer Discovery
    |June 30, 2016
    PubMed

    Insights

    Proteomic analysis of breast tumors reveals functional impacts of genetic mutations. Researchers found that chromosome 5q deletions may drive EGFR overexpression in basal-like breast cancer by losing SKP1 and CETN3 genes.

    Area of Science:

    • Oncology
    • Genomics
    • Proteomics

    Background:

    • Somatic mutations play a role in cancer development.
    • Understanding the functional consequences of these mutations is crucial for targeted therapies.

    Purpose of the Study:

    • To investigate the functional consequences of somatic mutations in breast cancer using proteomic analysis.
    • To identify specific genetic alterations and their impact on protein expression in different breast cancer subtypes.

    Main Methods:

    • Proteomic analysis using mass spectrometry.
    • Genomic characterization of 77 breast tumor samples.

    Main Results:

    • Identified functional consequences of somatic mutations through proteomic analysis.
    • Observed EGFR overexpression in basal-like breast cancer.
    • Linked EGFR overexpression to the loss of SKP1 and CETN3 genes due to chromosome 5q deletion in basal-like breast cancer.

    Conclusions:

    • The loss of SKP1 and CETN3 genes on chromosome 5q may be a driver of EGFR overexpression in basal-like breast cancer.
    • Proteomic analysis is a valuable tool for uncovering the functional impact of genetic mutations in cancer.